Adusumilli PS - Search Results

1

Driving CARs on the uneven road of antigen heterogeneity in solid tumors.

Chen N, Li X, Chintala NK, Tano ZE, Adusumilli PS. Chen N, et al. Among authors: adusumilli ps. Curr Opin Immunol. 2018 Apr;51:103-110. doi: 10.1016/j.coi.2018.03.002. Epub 2018 Mar 16. Curr Opin Immunol. 2018. PMID: 29554494 Free PMC article. Review.

2

Prognostic immune markers in non-small cell lung cancer.

Suzuki K, Kachala SS, Kadota K, Shen R, Mo Q, Beer DG, Rusch VW, Travis WD, Adusumilli PS. Suzuki K, et al. Among authors: adusumilli ps. Clin Cancer Res. 2011 Aug 15;17(16):5247-56. doi: 10.1158/1078-0432.CCR-10-2805. Epub 2011 Jun 9. Clin Cancer Res. 2011. PMID: 21659461 Review.

3

Immune responses and immunotherapeutic interventions in malignant pleural mesothelioma.

Bograd AJ, Suzuki K, Vertes E, Colovos C, Morales EA, Sadelain M, Adusumilli PS. Bograd AJ, et al. Among authors: adusumilli ps. Cancer Immunol Immunother. 2011 Nov;60(11):1509-27. doi: 10.1007/s00262-011-1103-6. Epub 2011 Sep 13. Cancer Immunol Immunother. 2011. PMID: 21913025 Free PMC article. Review.

4

Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity.

Adusumilli PS, Cherkassky L, Villena-Vargas J, Colovos C, Servais E, Plotkin J, Jones DR, Sadelain M. Adusumilli PS, et al. Sci Transl Med. 2014 Nov 5;6(261):261ra151. doi: 10.1126/scitranslmed.3010162. Sci Transl Med. 2014. PMID: 25378643 Free PMC article.

5

Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors.

Morello A, Sadelain M, Adusumilli PS. Morello A, et al. Among authors: adusumilli ps. Cancer Discov. 2016 Feb;6(2):133-46. doi: 10.1158/2159-8290.CD-15-0583. Epub 2015 Oct 26. Cancer Discov. 2016. PMID: 26503962 Free PMC article. Review.

6

CAR T-cell intrinsic PD-1 checkpoint blockade: A two-in-one approach for solid tumor immunotherapy.

Chen N, Morello A, Tano Z, Adusumilli PS. Chen N, et al. Among authors: adusumilli ps. Oncoimmunology. 2016 Dec 23;6(2):e1273302. doi: 10.1080/2162402X.2016.1273302. eCollection 2017. Oncoimmunology. 2016. PMID: 28344886 Free PMC article.

7

CAR T-cell therapy for pancreatic cancer.

DeSelm CJ, Tano ZE, Varghese AM, Adusumilli PS. DeSelm CJ, et al. Among authors: adusumilli ps. J Surg Oncol. 2017 Jul;116(1):63-74. doi: 10.1002/jso.24627. Epub 2017 Mar 27. J Surg Oncol. 2017. PMID: 28346697 Free PMC article. Review.

8

CAR T-cell therapy for lung cancer and malignant pleural mesothelioma.

Zeltsman M, Dozier J, McGee E, Ngai D, Adusumilli PS. Zeltsman M, et al. Among authors: adusumilli ps. Transl Res. 2017 Sep;187:1-10. doi: 10.1016/j.trsl.2017.04.004. Epub 2017 Apr 26. Transl Res. 2017. PMID: 28502785 Free PMC article. Review.

9

Novel immunotherapy clinical trials in malignant pleural mesothelioma.

Tano ZE, Chintala NK, Li X, Adusumilli PS. Tano ZE, et al. Among authors: adusumilli ps. Ann Transl Med. 2017 Jun;5(11):245. doi: 10.21037/atm.2017.03.81. Ann Transl Med. 2017. PMID: 28706913 Free PMC article.

10

Chimeric Antigen Receptor (CAR) T-Cell Therapy for Thoracic Malignancies.

Kiesgen S, Chicaybam L, Chintala NK, Adusumilli PS. Kiesgen S, et al. Among authors: adusumilli ps. J Thorac Oncol. 2018 Jan;13(1):16-26. doi: 10.1016/j.jtho.2017.10.001. Epub 2017 Oct 26. J Thorac Oncol. 2018. PMID: 29107016 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

344 results

Search Page

Filters